Page 1401 - Si Reporter

Heavyweights, banks decline

IT, realty and pharma stocks in green

Markets extend losses on US recession fears

Metal, financial stocks lead declines on BSE

Markets come off day highs

IT stocks remain top Sensex gainers

Markets consolidate gains, US woes weigh

Asian markets mixed in pre-holiday trades

Markets open up on hopes of US growth

Metals, autos, real-esate lead gains

Pre market: 4 stocks to watch out for today

Markets likely to trade volatile in the holiday shortened week

Markets end lower dragged by banks

RIL, ICICI Bank, SBI among top Sensex losers

Markets extend losses in noon deals

Bharti Airtel top loser among the Sensex stocks

Persistent Systems at record high on heavy volumes

Norwest Venture Partners FVCI ? Mauritius has sold 2.66 million shares through open market sale between December 17 and December 19.

Jet Airways slips 7% on heavy volumes

A combined 5.35 million shares have already changed hands till late noon deals against an average 5.5 million shares that were traded daily in past one week.

Indo Tech dips on delisting offer at steep discount

The company fixes the indicative price of Rs 120 per share for delisting of equity shares, much less than Thursday?s closing price of Rs 168 on the BSE.

Markets continue to trade lower on weak Asian cues

HDFC Group, ITC, RIL among top Sensex losers

Gulf Oil Corporation rises on completion of US acquisition

Through a step down subsidiary structure in the UK and USA, the company has completed acquisition of 100% stake in Houghton International Inc.

IFCI dips on equity dilution concerns

Allotted 523 million equity shares of the company at par i.e Rs 10 each to the Government of India on conversion of OCD's.

Cairn India dips on production concerns

Oil exploration and production firm may revise its production guidance in the third quarter results announcement in January 2013.

Adani up as promoters fix share-sale floor price at Rs 282 per share

The promoters propose to sell the company's 23 million shares through offer for sale (OFS) today.

Glenmark Pharma at 52-week high on signing pact with Forest Lab

The company has signed development agreement with Forest Laboratories for worldwide collaboration on Novel Agents to treat chronic inflammatory conditions.

Lanco Infra rallies as Australian court allows arm coal pact revision

The revised coal supply agreement will result in a gain of approximately AUD 150 million (approx. Rs 850 crore) in NPV terms.

FDC soars on promoter stake sale report

The Chandavarkar family, the promoters of pharma firm FDC, plan to sell their 67% stake in the company,report.

Aurobindo Pharma gains on USFDA nod for Ondansetron injections

The company has received final approvals for Ondansetron Injection, used to prevent nausea and vomiting caused by cancer chemotherapy and surgery.